Search results
European Authority Recommends Against Approval For Merck-Ridgeback Biotherapeutics' COVID-19 Pill
Benzinga via Yahoo Finance· 1 year agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced that the Committee for Medicinal...
UK Study Shows Merck's COVID-19 Antiviral Pill Did Not Cut Hospitalization Risk
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced data from two real-world evidence...
Merck, Ridgeback Announce New Molnupiravir Data From Late-Stage COVID-19 Study
Benzinga via Yahoo Finance· 2 years agoMerck & Co Inc (NYSE: MRK) and Ridgeback Biotherapeutics announced that the Annals of Internal...
UPDATE 4-Merck, Ridgeback withdraw COVID drug application in EU
Reuters via Yahoo Finance· 10 months agoMerck and Co and partner Ridgeback Biotherapeutics said on Tuesday they had withdrawn their COVID-19 pill application in the European Union, months after the region's regulator did not back ...
Merck Partner Joins Forces With Emergent Bio To Increase Access To Ebola Treatment
Benzinga via Yahoo Finance· 2 years agoEmergent BioSolutions Inc (NYSE: EBS) has agreed to create a collaboration with Ridgeback...
Merck-Ridgeback withdraw EU COVID drug application
Reuters via Yahoo Finance· 10 months agoJune 27 (Reuters) - Merck and Co and Ridgeback Biotherapeutics have withdrawn their European Union application for COVID-19 pill Lagevrio after the region's regulator cited insufficient data ...
IBD Stock Of The Day Merck Notches Quarterly Beat As Covid Pill Brings In $3.2 Billion
Investor's Business Daily· 2 years agoMerck is the IBD Stock Of The Day after notching a quarterly beat that included $3.2 billion in...
Merck Outplays The Covid Decline, But Prometheus Buyout Weighs On Profits
Investor's Business Daily· 9 months agoMerck topped Wall Street's second-quarter expectations Tuesday, though it reported a per-share loss...
Merck to take legal action against unauthorized distributors of its COVID treatment in China
Reuters via Yahoo News· 1 year agoSHANGHAI (Reuters) -Merck & Co said on Wednesday it would take legal action against some...
Merck Dives As Drug-Pricing Bills Undercut Second-Quarter Profit
Investor's Business Daily· 2 years agoMerck stock tumbled amid a broad pharma turndown Thursday even though the company racked up more...
